Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Reg Anesth Pain Med ; 41(4): 430-7, 2016.
Article in English | MEDLINE | ID: mdl-27281720

ABSTRACT

BACKGROUND AND OBJECTIVES: This prospective, randomized, double-blind study compared the effects of the ultrasound-guided popliteal sciatic nerve block performed by either intraneural or subparaneural approach followed by an electrophysiological evaluation. We hypothesized that intraneural injection provides a faster onset with a better success rate compared with the subparaneural approach. METHODS: Eighty-eight patients were enrolled and randomized to receive an ultrasound-guided popliteal sciatic nerve block injecting 15 mL ropivacaine 1% according to an intraneural injection (group INTRA = 44) or a subparaneural injection (group SUBPARA = 44). The primary end point was the onset time of sensory and motor block, whereas secondary end points were successful, duration of the block, and the variation of the electrophysiological assessment after 5 weeks. The study was registered prior to patient enrollment (clinicaltrials.gov identifier NCT01987128). RESULTS: The median onset time for successful sciatic nerve block in the INTRA group was 10 (5-15 [5-30]) minutes versus 25 (15-35 [5-45]) minutes in the SUBPARA group (P < 0.001), with a rate of 41/43 (95.3%) compared with 25/40 (62.5%) in the SUBPARA group (P < 0.001). No difference was found regardless of the duration of the block. Fifty-three patients also performed the electrophysiological assessment at 5 weeks, showing a subclinical, significant reduction in amplitude of the action potentials with no difference between groups. No patients reported any clinical neurological complications after 6 months. CONCLUSIONS: In ultrasound-guided popliteal sciatic nerve block, intraneural injection provided a faster onset and better success rate compared with subparaneural. Both techniques resulted in a similar subclinical reduction in amplitude of the sciatic action potentials at 5 weeks after surgery. These findings should not be extended to other approaches.


Subject(s)
Amides/administration & dosage , Anesthetics, Local/administration & dosage , Nerve Block/methods , Neural Conduction/drug effects , Sciatic Nerve/drug effects , Sciatic Nerve/diagnostic imaging , Ultrasonography, Interventional , Action Potentials/drug effects , Adult , Aged , Aged, 80 and over , Amides/adverse effects , Anesthetics, Local/adverse effects , Double-Blind Method , Electric Stimulation , Female , Humans , Injections , Italy , Male , Middle Aged , Motor Activity/drug effects , Nerve Block/adverse effects , Neurologic Examination/methods , Prospective Studies , Ropivacaine , Sensory Thresholds/drug effects , Time Factors , Treatment Outcome
2.
Anesth Analg ; 119(2): 489-493, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24914630

ABSTRACT

BACKGROUND: Among the various factors influencing the success rate, onset time, and duration of peripheral nerve blocks, the role of local anesthetics concentration remains uncertain. In this prospective, randomized, single-blinded study, we evaluated whether varying the dilution of a fixed dose of mepivacaine solution influenced onset time and duration of sciatic nerve block. METHODS: Ninety ASA physical status I to II patients scheduled for foot surgery were randomly allocated to receive a double-injection Labat sciatic nerve block with 12 mL mepivacaine 2% (group concentration I = 45 patients) or 24 mL of mepivacaine 1% (group volume II = 45 patients). The nerve stimulator was initially set at 2 Hz, 0.1 millisecond, 1 mA. The total amount of local anesthetic (240 mg) was kept constant and equally divided between the peroneal and tibial nerves. All patients also received an ultrasound-guided popliteal sciatic nerve catheter for postoperative analgesia. Times to readiness for surgery, performance, and offset of local anesthetic were recorded. Our primary end point was to determine a possible difference in offset time between groups. Continuous variables were expressed as median (IQR) and compared with the Wilcoxon-Mann-Whitney U test; WMWodds are reported together with their 95% confidence interval. RESULTS: The overall success rate of sciatic nerve block was 99%. Time of performance was shorter in group I, 120 seconds (90-150 seconds), than that in group II, 150 seconds (120-180 seconds) (P = 0.0048; WMWodds 2.26 [1.35-4.34]). The onset time of sensory and motor sciatic nerve block was 4 minutes (2-9 minutes) in group I and 6 minutes (4-10 minutes) in group II (P = 0.41; WMWodds 1.21 [0.77-1.95]), while the duration of sensory block was 235 minutes (203-250 minutes) in group I, and 240 minutes (218-247 minutes) in group II respectively (P = 0.51; WMWodds 1.20 [0.69-2.16]). CONCLUSIONS: We found no evidence that varying volume and concentration while maintaining a fixed total dose of mepivacaine alters the onset time and duration of double-injection sciatic nerve block. Considering our WMWodds results, possible differences in onset time and duration comparable to differences in the performance time between groups cannot be excluded.


Subject(s)
Anesthetics, Local/administration & dosage , Foot/innervation , Mepivacaine/administration & dosage , Nerve Block/methods , Sciatic Nerve/drug effects , Adult , Aged , Aged, 80 and over , Chi-Square Distribution , Dose-Response Relationship, Drug , Female , Foot/surgery , Humans , Injections , Italy , Kaplan-Meier Estimate , Logistic Models , Male , Middle Aged , Motor Activity/drug effects , Odds Ratio , Pain Threshold/drug effects , Prospective Studies , Single-Blind Method , Time Factors , Treatment Outcome , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...